Long-term Efficacy Results of Eortc Gu Group Study 30911 Comparing Epirubicin, Bacillus Calmetteguerin (bcg), and Bcg Plus Isoniazid in Patients With Intermediate and High Risk Stage Ta T1 Papillary Carcinoma of the Bladder
Year: 2008
Type: conference-abstract
Source: European Urology Supplements
Authors: R.J. Sylvester, M.A. Brausi, W. Hoeltl, P.H. Powell, P. Whelan, T. Gorlia, T.M. De Reijke
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2016870591